Despite the therapeutic potential, targeting TAMs presents several challenges. One major issue is the plasticity of macrophages, which allows them to rapidly change their phenotype in response to environmental cues. This makes it difficult to achieve a sustained therapeutic effect. Additionally, TAM-targeted therapies may also affect normal macrophages in other tissues, leading to unintended side effects such as immunosuppression or impaired tissue repair.
